Determination of 1,25-dihydroxyvitamin D concentrations in human colon tissues and matched serum samples

Anticancer Research

Volumn 32, Issue 1 PART 2, 2012, Pages 259-263

  Wagner, Dennis ^a,b   Dias, Andre G ^a   Schnabl, Kareena ^c,d   Van Der Kwast, Theodorus ^e   Vieth, Reinhold ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

1,25 dihydroxyvitamin D; Colon; Colon cancer; Colorectal; Methodology; Tissue level; Vitamin D

Indexed keywords

CALCITRIOL; VITAMIN D BINDING PROTEIN;

BLOOD LEVEL; CLINICAL ARTICLE; COLON; COLON RESECTION; CONFERENCE PAPER; ENZYME IMMUNOASSAY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SERUM;

COLON; HUMANS; IMMUNOENZYME TECHNIQUES; MUCOUS MEMBRANE; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84855989071     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK and Gorham ED: Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2: 1176-1178, 1989. (Pubitemid 19275448)
2. Ma Y, Zhang P, Wang F, Yang J, Liu Z and Qin H: Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29: 3775-3782, 2011.
3. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M and Holick MF: Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 97: 179-194, 2005. (Pubitemid 41546228)
4. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M and Holick MF: Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 32: 210-216, 2007. (Pubitemid 46223622)
5. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL and Fuchs CS: Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26: 2984-2991, 2008.
6. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR and Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85: 1586-1591, 2007. (Pubitemid 46890428)
7. 3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev 9: 265-270, 2000.
8. 3-1-alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52: 985-989, 2004.
9. 3 in seven human prostatic carcinoma cell lines. Clin Cancer Res 1: 997-1003, 1995.
10. 3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha- hydroxylated vitamin D analogue. Breast Cancer Res 7: R980-R986, 2005.
11. Cross HS, Bajna E, Bises G, Genser D, Kallay E, Potzi R, Wenzl E, Wrba F, Roka R and Peterlik M: Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res 16: 2333-2337, 1996.
12. Holick MF: Vitamin D deficiency. N Engl J Med 357: 266-281, 2007.
13. Garland CF, Gorham ED, Mohr SB and Garland FC: Vitamin D for cancer prevention: global perspective. Ann Epidemiol 19: 468-483, 2009.
14. Cross HS: Extrarenal vitamin D hydroxylase expression and activity in normal and malignant cells: modification of expression by epigenetic mechanisms and dietary substances. Nutr Rev 65: S108-S112, 2007.
15. Fleet JC, Hong J and Zhang Z: Reshaping the way we view vitamin D signalling and the role of vitamin D in health. Nutr Res Rev 17: 241-248, 2004.
16. Vieth R: How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 29: 3675-3684, 2009.
17. 3 levels and apoptosis in female mice on a calcium-deficient diet. Anticancer Res 29: 3727-3732, 2009.
18. 3 fortification, quantification, and long-term stability in Cheddar and low-fat cheeses. J Agric Food Chem 56: 7964-7969, 2008.
19. 3 concentration. J Clin Invest 67: 589-596, 1981.
20. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T and Dawson-Hughes B: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18-28, 2006. (Pubitemid 44699167)